✦ LIBER ✦

Ocular myasthenia gravis: response to long term immunosuppressive treatment

✍ Scribed by Sigg, B; Melms, A; Weller, M; Schepelmann, K; Herzau, V; Dichgans, J; Sommer, N

Book ID: 125825458
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 297 KB
Volume: 124
Category: Article
ISSN: 0002-9394
DOI: 10.1016/S0002-9394(14)71723-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ocular myasthenia gravis: response to lo

Ocular myasthenia gravis: response to long term immunosuppressive treatment: Sommer N, Sigg B, Melms A, et al. J Neurol Neurosurg Psychiatry 1997;62:156-62

📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 203 KB

Immunosuppressive or Surgical Treatment

Immunosuppressive or Surgical Treatment for Ocular Myasthenia Gravis

✍ Chavis, Pamela S.; Stickler, David E.; Walker, Aljoeson 📂 Article 📅 2007 🏛 American Medical Association 🌐 English ⚖ 56 KB

Long-term Outcomes of Pediatric Ocular M

Long-term Outcomes of Pediatric Ocular Myasthenia Gravis

✍ Steve Ortiz; Mark Borchert 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 246 KB

Long-Term Corticosteroid Treatment of My

Long-Term Corticosteroid Treatment of Myasthenia Gravis

✍ T. R. JOHNS 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 799 KB

Intermittent long-term adrenocorticoster

Intermittent long-term adrenocorticosteroid treatment of myasthenia gravis

✍ Nobou Wakata; Yuko Kawamura; Masako Kobayashi; You Araki; Masao Kinoshita 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 250 KB

It is widely accepted that a long-term, alternate-day administration of adrenal corticosteroids after thymectomy is one of the most effective treatments of myasthenia gravis. However, some patients with myasthenia gravis show a tendency to develop steroid dependency, and require extremely prolonged

Long-term treatment of myasthenia gravis

Long-term treatment of myasthenia gravis with immunoadsorption

✍ Martin Haas; Norbert Mayr; Josef Zeitlhofer; Andreas Goldammer; Kurt Derfler 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

Acute treatment of myasthenic crisis with immunoadsorption (IA) or plasma exchange is well established. The efficiency of chronic apheresis therapy in myasthenia gravis (MG), however, and its efficacy in reducing concomitant potentially harmful immunosuppressive therapy, is unknown. We treated 13 pa